Information Provided By:
Fly News Breaks for January 13, 2020
Jan 13, 2020 | 09:19 EDT
As previously reported, BofA analyst Chris Carey initiated coverage of Tilray with a Neutral rating and $18 price target. While Tilray's portfolio diversity could provide more upside compared to Canada-focused peers, he is preferring to be selective in his approach to 2020 in terms of the cannabis space, Carey tells investors.